English
Insider transactions
EDGARPHATHOM PHARMACEUTICALS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–45 of 45
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-06 Filed 2026-10-08 | Narula Sanjeev Officer: Chief Financial Bus. Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 13,485 | 6.78 | 91,428.3Derived: shares × price per share. Exact value 91428.30. | 214,718 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-418114 Read from the filing’s XML Dispute this row |
| 2026-09-03 Filed 2026-09-08 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 460 | 9.05 | 4,163Derived: shares × price per share. Exact value 4163.00. | 59,465 | Direct (D) | No | F1
| Open filing 0001193125-26-385250 Read from the filing’s XML Dispute this row |
| 2026-07-14 Filed 2026-07-16 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,555 | 11.035 | 17,159.425Derived: shares × price per share. Exact value 17159.425. | 59,925 | Direct (D) | No | F1
| Open filing 0001193125-26-306165 Read from the filing’s XML Dispute this row |
| 2026-05-22 Filed 2026-05-27 | Parikh Asit Director | GBona fide gift | Disposed (D) | 28,000 | 0 | — | 24,122 | Direct (D) | No | — | Open filing 0001193125-26-241984 Read from the filing’s XML Dispute this row |
| 2026-05-22 Filed 2026-05-27 | Parikh Asit Director | GBona fide gift | Acquired (A) | 28,000 | 0 | — | 148,500 | Indirect (I) by Trust | No | F1
| Open filing 0001193125-26-241984 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-21 | Parikh Asit Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 17,500 | 4.95 | 86,625Derived: shares × price per share. Exact value 86625.00. | 52,122 | Direct (D) | No | — | Open filing 0001193125-26-234891 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-21 | Parikh Asit Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 17,500 | 0 | — | 0 | Direct (D) | No | — | Open filing 0001193125-26-234891 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Schroeder Theodore R Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 45,122 | Direct (D) | No | F1
| Open filing 0001193125-26-234563 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Stenhouse Mark Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 54,122 | Direct (D) | No | F1
| Open filing 0001193125-26-234568 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | KARBE FRANK Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 91,622 | Direct (D) | No | F1
| Open filing 0001193125-26-234564 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Parikh Asit Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 34,622 | Direct (D) | No | F1
| Open filing 0001193125-26-234891 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | FIELDS HEIDI Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 54,122 | Direct (D) | No | F1
| Open filing 0001193125-26-234567 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | COLA MICHAEL F Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 63,920 | Direct (D) | No | F1
| Open filing 0001193125-26-234566 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Topper James N Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,122 | 0 | — | 66,718 | Direct (D) | No | F1
| Open filing 0001193125-26-234572 Read from the filing’s XML Dispute this row |
| 2026-03-10 Filed 2026-03-11 | Parikh Asit Director | GBona fide gift | Disposed (D) | 40,000 | 0 | — | 10,500 | Direct (D) | No | — | Open filing 0001193125-26-102632 Read from the filing’s XML Dispute this row |
| 2026-03-10 Filed 2026-03-11 | Parikh Asit Director | GBona fide gift | Acquired (A) | 40,000 | 0 | — | 120,500 | Indirect (I) by Trust | No | F1
| Open filing 0001193125-26-102632 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Breedlove Robert Charles Officer: Principal Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 13,000 | 0 | — | 60,068 | Direct (D) | No | F1
| Open filing 0001193125-26-088730 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Breedlove Robert Charles Officer: Principal Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,790 | 0 | — | 62,858 | Direct (D) | No | F2
| Open filing 0001193125-26-088730 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 964 | 12.56 | 12,107.84Derived: shares × price per share. Exact value 12107.84. | 61,894 | Direct (D) | No | F3
| Open filing 0001193125-26-088730 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 414 | 12.56 | 5,199.84Derived: shares × price per share. Exact value 5199.84. | 61,480 | Direct (D) | No | F4
| Open filing 0001193125-26-088730 Read from the filing’s XML Dispute this row |
| 2026-02-10 Filed 2026-02-12 | Basta Steven L Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,362 | 0 | — | 379,592 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-048867 Read from the filing’s XML Dispute this row |
| 2026-02-10 Filed 2026-02-12 | Basta Steven L Director · Officer: President and CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 6,277 | 12.82 | 80,471.14Derived: shares × price per share. Exact value 80471.14. | 373,315 | Direct (D) | No | F3
| Open filing 0001193125-26-048867 Read from the filing’s XML Dispute this row |
| 2026-02-10 Filed 2026-02-12 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,461 | 0 | — | 90,195 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-048881 Read from the filing’s XML Dispute this row |
| 2026-02-10 Filed 2026-02-12 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,535 | 12.82 | 19,678.7Derived: shares × price per share. Exact value 19678.70. | 88,660 | Direct (D) | No | F3
| Open filing 0001193125-26-048881 Read from the filing’s XML Dispute this row |
| 2026-01-23 Filed 2026-01-27 | Parikh Asit Director | GBona fide gift | Disposed (D) | 80,500 | 0 | — | 50,500 | Direct (D) | No | — | Open filing 0001193125-26-024600 Read from the filing’s XML Dispute this row |
| 2026-01-23 Filed 2026-01-27 | Parikh Asit Director | GBona fide gift | Acquired (A) | 80,500 | 0 | — | 80,500 | Indirect (I) by Trust | No | F1, F2
| Open filing 0001193125-26-024600 Read from the filing’s XML Dispute this row |
| 2026-01-21 Filed 2026-01-23 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 776 | 13.61 | 10,561.36Derived: shares × price per share. Exact value 10561.36. | 47,068 | Direct (D) | No | F1
| Open filing 0001193125-26-021164 Read from the filing’s XML Dispute this row |
| 2026-01-13 Filed 2026-01-15 | Parikh Asit Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 8,750 | 10.3 | 90,125Derived: shares × price per share. Exact value 90125.0. | 131,000 | Direct (D) | No | — | Open filing 0001193125-26-014187 Read from the filing’s XML Dispute this row |
| 2026-01-13 Filed 2026-01-15 | Parikh Asit Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,750 | 0 | — | 0 | Direct (D) | No | — | Open filing 0001193125-26-014187 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Narula Sanjeev Officer: Chief Financial Bus. Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 82,715 | 0 | — | 226,715 | Direct (D) | No | F1
| Open filing 0001193125-26-001123 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Narula Sanjeev Officer: Chief Financial Bus. Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,848 | 0 | — | 42,848 | Direct (D) | No | F2
| Open filing 0001193125-26-001123 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Basta Steven L Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 251,034 | 0 | — | 364,820 | Direct (D) | No | F1
| Open filing 0001193125-26-001127 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Basta Steven L Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 226,156 | 0 | — | 221,156 | Direct (D) | No | F2
| Open filing 0001193125-26-001127 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 75,345 | 0 | — | 85,012 | Direct (D) | No | F1
| Open filing 0001193125-26-001125 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-02 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 67,878 | 0 | — | 67,878 | Direct (D) | No | F2
| Open filing 0001193125-26-001125 Read from the filing’s XML Dispute this row |
| 2025-12-19 Filed 2025-12-23 | Parikh Asit Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 8,750 | 10.3 | 90,125Derived: shares × price per share. Exact value 90125.0. | 122,250 | Direct (D) | No | — | Open filing 0001193125-25-331104 Read from the filing’s XML Dispute this row |
| 2025-12-19 Filed 2025-12-23 | Parikh Asit Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,750 | 0 | — | 8,750 | Direct (D) | No | — | Open filing 0001193125-25-331104 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | Breedlove Robert Charles Officer: Principal Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 230 | 16.28 | 3,744.4Derived: shares × price per share. Exact value 3744.40. | 47,844 | Direct (D) | No | F1
| Open filing 0001193125-25-327135 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | Basta Steven L Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,038 | 0 | — | 145,288 | Direct (D) | No | F1
| Open filing 0001193125-25-327126 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | Basta Steven L Director · Officer: President and CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 31,502 | 15.36 | 483,870.72Derived: shares × price per share. Exact value 483870.72. | 113,786 | Direct (D) | No | F2
| Open filing 0001193125-25-327126 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 17,370 | 0 | — | 17,370 | Direct (D) | No | F1
| Open filing 0001193125-25-327131 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | Cook Anne Marie Officer: Chief Legal Off. Corp. Sec. | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 7,703 | 15.36 | 118,318.08Derived: shares × price per share. Exact value 118318.08. | 9,667 | Direct (D) | No | F2
| Open filing 0001193125-25-327131 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-02 | Basta Steven L Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 90,000 | 0 | — | 131,625 | Direct (D) | No | — | Open filing 0001193125-25-305575 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-02 | Basta Steven L Director · Officer: President and CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 48,375 | 15.62 | 755,617.5Derived: shares × price per share. Exact value 755617.50. | 83,250 | Direct (D) | No | F1
| Open filing 0001193125-25-305575 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-02 | Basta Steven L Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 90,000 | 0 | — | 180,000 | Direct (D) | No | F2, F3
| Open filing 0001193125-25-305575 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 173
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 12,466,489 SH | 91,005,370 dollars | Unchanged Prior quarter: 12,466,489 | Open filing 0001892134-26-000007 Filed 2026-11-16 Dispute this row |
| Medicxi Ventures Management (Jersey) Ltd Partly reported under another manager | 7,464,572 SH | 54,491,376 dollars | Unchanged Prior quarter: 7,464,572 | Open filing 0001193125-26-442882 Filed 2026-11-02 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 5,246,260 SH | 38,297,700 dollars | Higher by 721,131 Prior quarter: 4,525,129 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Carlyle Group Inc. Partly reported under another manager | 3,496,808 SH | 25,526,698 dollars | Unchanged Prior quarter: 3,496,808 | Open filing 0000898432-26-000769 Filed 2026-11-06 Dispute this row |
| WASATCH ADVISORS LP Partly reported under another manager | 2,942,432 SH | 21,479,754 dollars | Higher by 1,635,185 Prior quarter: 1,307,247 | Open filing 0000814133-26-000137 Filed 2026-10-13 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,735,113 SH | 19,966,325 dollars | Higher by 78,169 Prior quarter: 2,656,944 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 2,406,391 SH | 13,668,301 dollars | Higher by 435,563 Prior quarter: 1,970,828 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 2,400,970 SH | 17,527,081 dollars | Lower by 974,864 Prior quarter: 3,375,834 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| GWK Investment Management, LLC | 2,128,822 SH | 15,540 dollars | Lower by 38,016 Prior quarter: 2,166,838 | Open filing 0001082917-26-000006 Filed 2026-11-10 Dispute this row |
| 683 Capital Management, LLC Partly reported under another manager | 2,000,000 SH | 14,600,000 dollars | Higher by 150,000 Prior quarter: 1,850,000 | Open filing 0001404574-26-000027 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 1,997,876 SH | 14,584,495 dollars | Higher by 411,553 Prior quarter: 1,586,323 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| NEA Management Company, LLC | 1,960,169 SH | 14,309,234 dollars | Unchanged Prior quarter: 1,960,169 | Open filing 0001072613-26-000901 Filed 2026-11-16 Dispute this row |
| Catalys Pacific, LLC | 1,882,039 SH | 13,738,885 dollars | Higher by 388,185 Prior quarter: 1,493,854 | Open filing 0001104659-26-120524 Filed 2026-10-30 Dispute this row |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager | 1,835,701 SH | 13,400,617 dollars | Higher by 372,963 Prior quarter: 1,462,738 | Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 1,501,268 SH | 10,959,256 dollars | Higher by 479,075 Prior quarter: 1,022,193 | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 1,334,654 SH | 9,744,614 dollars | Higher by 18,967 Prior quarter: 1,315,687 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Propel Bio Management, LLC Partly reported under another manager | 1,105,913 SH | 8,073,165 dollars | Higher by 55,555 Prior quarter: 1,050,358 | Open filing 0001829126-26-012373 Filed 2026-11-13 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 967,895 SH | 7,065,634 dollars | Higher by 673,916 Prior quarter: 293,979 | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 894,675 SH | 6,531,127 dollars | Lower by 883,357 Prior quarter: 1,778,032 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Trexquant Investment LP Partly reported under another manager | 855,542 SH | 6,245,457 dollars | Higher by 681,658 Prior quarter: 173,884 | Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row |
| Ensign Peak Advisors, Inc | 813,983 SH | 5,942,076 dollars | Lower by 237,930 Prior quarter: 1,051,913 | Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row |
| HSBC HOLDINGS PLC Partly reported under another manager | 812,913 SH | 5,943,298 dollars | Higher by 103,218 Prior quarter: 709,695 | Open filing 0000873630-26-000005 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 679,320 SH | 4,959,036 dollars | Lower by 117,311 Prior quarter: 796,631 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 490,308 SH | 3,579,248 dollars | Higher by 71,214 Prior quarter: 419,094 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 467,802 SH | 3,414,955 dollars | Higher by 9,501 Prior quarter: 458,301 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Option: Call Partly reported under another manager | 451,900 SH | 3,298,870 dollars | Lower by 28,900 Prior quarter: 480,800 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 423,613 SH | 3,092,375 dollars | Lower by 95,463 Prior quarter: 519,076 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| StepStone Group LP | 422,085 SH | 3,081,221 dollars | Unchanged Prior quarter: 422,085 | Open filing 0001193125-26-465186 Filed 2026-11-17 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 394,315 SH | 2,878,500 dollars | Higher by 39,742 Prior quarter: 354,573 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Hennion Walsh Asset Management, Inc. | 392,392 SH | 2,864,462 dollars | Higher by 65,114 Prior quarter: 327,278 | Open filing 0002000324-26-005579 Filed 2026-10-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 376,377 SH | 2,747,553 dollars | Higher by 171,804 Prior quarter: 204,573 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Woodline Partners LP | 369,357 SH | 2,696,306 dollars | Higher by 305 Prior quarter: 369,052 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 343,670 SH | 2,508,791 dollars | Higher by 158,769 Prior quarter: 184,901 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Jones Hill Capital LP | 276,830 SH | 2,020,859 dollars | Higher by 115,344 Prior quarter: 161,486 | Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 273,767 SH | 2,014,925 dollars | Lower by 1,484 Prior quarter: 275,251 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 249,556 SH | 1,821,759 dollars | Higher by 113,724 Prior quarter: 135,832 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| Simplify Asset Management Inc. | 249,267 SH | 1,819,649 dollars | Unchanged Prior quarter: 249,267 | Open filing 0001172661-26-004722 Filed 2026-10-27 Dispute this row |
| GROUP ONE TRADING LLC Option: Call | 245,200 SH | 1,789,960 dollars | Higher by 89,600 Prior quarter: 155,600 | Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 241,980 SH | 1,766,453 dollars | Higher by 146,320 Prior quarter: 95,660 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 227,955 SH | 1,664,072 dollars | Not in the prior quarter’s filings read | Open filing 0000884414-26-000004 Filed 2026-11-16 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 196,286 SH | 1,432,888 dollars | Higher by 187,594 Prior quarter: 8,692 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| NewEdge Advisors, LLC | 189,195 SH | 1,381,124 dollars | Lower by 14,767 Prior quarter: 203,962 | Open filing 0001213900-26-119695 Filed 2026-11-13 Dispute this row |
| WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager | 180,214 SH | 1,315,562 dollars | Higher by 47,930 Prior quarter: 132,284 | Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row |
| DIADEMA PARTNERS LP | 179,950 SH | 1,313,635 dollars | Higher by 50,000 Prior quarter: 129,950 | Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 163,400 SH | 1,192,820 dollars | Lower by 46,900 Prior quarter: 210,300 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| Virtus Investment Advisers, LLC Partly reported under another manager | 162,536 SH | 1,186,513 dollars | Higher by 50,397 Prior quarter: 112,139 | Open filing 0000019481-26-000011 Filed 2026-11-12 Dispute this row |
| Schonfeld Strategic Advisors LLC | 160,104 SH | 1,168,757 dollars | Not in the prior quarter’s filings read | Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 157,066 SH | 1,146,582 dollars | Higher by 6,051 Prior quarter: 151,015 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 156,308 SH | 1,141,049 dollars | Higher by 3,995 Prior quarter: 152,313 | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 140,601 SH | 1,026,387 dollars | Higher by 109,006 Prior quarter: 31,595 | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- SummitTX Capital, L.P. 789,550 SH
- MARSHALL WACE, LLP 666,090 SH
- EcoR1 Capital, LLC 625,000 SH
- PERCEPTIVE ADVISORS LLC 532,000 SH
- Sixth Street Partners Management Company, L.P. 419,094 SH
- JANE STREET GROUP, LLC 212,706 SH
- Avidity Partners Management LP 200,000 SH
- Opaleye Management Inc. 185,589 SH
- Stratos Wealth Partners, LTD. 100,000 SH
- Stonepine Capital Management, LLC 85,010 SH
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 77,316 SH
- Birchview Capital, LP 55,000 SH
- NOMURA HOLDINGS INC 49,100 SH
- Man Group plc 48,679 SH
- NOMURA HOLDINGS INC 40,000 SH
- Y-Intercept (Hong Kong) Ltd 39,845 SH
- ALLSTATE CORP 32,875 SH
- CITADEL ADVISORS LLC 31,100 SH
- GSA CAPITAL PARTNERS LLP 30,138 SH
- Caption Management, LLC 24,000 SH
- Jupiter Topco LLC 21,500 SH
- State of Wyoming 17,639 SH
- LAZARD ASSET MANAGEMENT LLC 14,671 SH
- TOCQUEVILLE ASSET MANAGEMENT L.P. 12,000 SH
- INTECH INVESTMENT MANAGEMENT LLC 11,388 SH
- Fulcrum Asset Management LLP 4,458 SH
- MERCER GLOBAL ADVISORS INC /ADV 1,337 SH
- Strategic Wealth Advisors LLC 1,000 SH
- GROUP ONE TRADING LLC 900 SH
- MassMutual Private Wealth Trust, FSB 427 SH
- Truvestments Capital LLC 225 SH
- Optiver Holding B.V. 90 SH
- Stone House Investment Management, LLC 8 SH
- Clearstead Advisors, LLC 5 SH
- Integrated Wealth Concepts LLC 4 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. Common Stock, $0.0001 par value per share | 6.5 | 5,323,356.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLSP, L.P. Common Stock, $0.0001 par value per share | 6.5 | 5,323,356.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLSP, L.L.C. Common Stock, $0.0001 par value per share | 6.5 | 5,323,356.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Frazier Life Sciences X, L.P. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS X, L.P. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS X, L.L.C. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Frazier Life Sciences XI, L.P. Common Stock, $0.0001 par value per share | 1.2 | 980,286.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS XI, L.P. Common Stock, $0.0001 par value per share | 1.2 | 980,286.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS XI, L.L.C. Common Stock, $0.0001 par value per share | 1.2 | 980,286.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Frazier Life Sciences IX, L.P. Common Stock, $0.0001 par value per share | 7.2 | 5,827,415.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS IX, L.P. Common Stock, $0.0001 par value per share | 7.2 | 5,827,415.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS IX, L.L.C. Common Stock, $0.0001 par value per share | 7.2 | 5,827,416.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Frazier Life Sciences XII, L.P. Common Stock, $0.0001 par value per share | 0.3 | 276,029.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS XII, L.P. Common Stock, $0.0001 par value per share | 0.3 | 276,029.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| FHMLS XII, L.L.C. Common Stock, $0.0001 par value per share | 0.3 | 276,029.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| James N. Topper Common Stock, $0.0001 par value per share | 7.4 | 6,013,327.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Patrick J. Heron Common Stock, $0.0001 par value per share | 7.3 | 5,901,756.00 | 10/29/2026 Filed 2026-11-02 | SCHEDULE 13D/AAmendment 12 | Open filing 0001231919-26-001523 Dispute this row |
| Invesco Ltd. Common Stock | 0.0 | 30,562.00 | 09/30/2026 Filed 2026-11-10 | SCHEDULE 13G/AAmendment 5 | Open filing 0000914208-26-000448 Dispute this row |
| BlackRock, Inc. Common Stock | 5.5 | 4,378,647 | 06/30/2026 Filed 2026-07-29 | SCHEDULE 13G | Open filing 0002012383-26-002854 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 4.2 | 3,375,834.00 | 06/30/2026 Filed 2026-07-20 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-085122 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 4.2 | 3,375,834.00 | 06/30/2026 Filed 2026-07-20 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-085122 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 4.2 | 3,375,834.00 | 06/30/2026 Filed 2026-07-20 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-085122 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 5.3 | 4,178,411.00 | 03/06/2026 Filed 2026-03-12 | SCHEDULE 13G | Open filing 0001104659-26-027124 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 5.3 | 4,178,411.00 | 03/06/2026 Filed 2026-03-12 | SCHEDULE 13G | Open filing 0001104659-26-027124 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 5.3 | 4,178,411.00 | 03/06/2026 Filed 2026-03-12 | SCHEDULE 13G | Open filing 0001104659-26-027124 Dispute this row |
| Integrated Core Strategies (US) LLC Common Stock, par value $0.0001 per share | 1.6 | 1,255,161.00 | 12/31/2025 Filed 2026-01-27 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-007000 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 2.7 | 2,082,180.00 | 12/31/2025 Filed 2026-01-27 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-007000 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 2.7 | 2,082,180.00 | 12/31/2025 Filed 2026-01-27 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-007000 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 2.7 | 2,082,180.00 | 12/31/2025 Filed 2026-01-27 | SCHEDULE 13G/AAmendment 3 | Open filing 0001104659-26-007000 Dispute this row |
| Frazier Life Sciences Public Fund, L.P. Common Stock, $0.0001 par value per share | 7.5 | 5,323,356.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLSP, L.P. Common Stock, $0.0001 par value per share | 7.5 | 5,323,356.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLSP, L.L.C. Common Stock, $0.0001 par value per share | 7.5 | 5,323,356.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Frazier Life Sciences X, L.P. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS X, L.P. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS X, L.L.C. Common Stock, $0.0001 par value per share | 0.1 | 59,403.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Frazier Life Sciences XI, L.P. Common Stock, $0.0001 par value per share | 1.4 | 980,286.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS XI, L.P. Common Stock, $0.0001 par value per share | 1.4 | 980,286.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS XI, L.L.C. Common Stock, $0.0001 par value per share | 1.4 | 980,286.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Frazier Life Sciences IX, L.P. Common Stock, $0.0001 par value per share | 8.2 | 5,827,415.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS IX, L.P. Common Stock, $0.0001 par value per share | 8.2 | 5,827,415.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS IX, L.L.C. Common Stock, $0.0001 par value per share | 8.2 | 5,827,416.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Frazier Life Sciences XII, L.P. Common Stock, $0.0001 par value per share | 0.4 | 276,029.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS XII, L.P. Common Stock, $0.0001 par value per share | 0.4 | 276,029.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| FHMLS XII, L.L.C. Common Stock, $0.0001 par value per share | 0.4 | 276,029.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| James N. Topper Common Stock, $0.0001 par value per share | 8.6 | 5,985,327.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Patrick J. Heron Common Stock, $0.0001 par value per share | 8.4 | 5,901,756.00 | 11/01/2025 Filed 2025-11-04 | SCHEDULE 13D/AAmendment 11 | Open filing 0001231919-25-000418 Dispute this row |
| Integrated Core Strategies (US) LLC Common Stock, par value $0.0001 per share | 5.8 | 4,149,826.00 | 09/30/2025 Filed 2025-11-03 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-105568 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 7.1 | 5,081,451.00 | 09/30/2025 Filed 2025-11-03 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-105568 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 7.1 | 5,081,451.00 | 09/30/2025 Filed 2025-11-03 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-105568 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 7.1 | 5,081,451.00 | 09/30/2025 Filed 2025-11-03 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-105568 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,655,474 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 72,561 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.